Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer-Reference-Cited by-同舟云学术

Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer

Published:2021-04 Issue:4 Volume:29 Page:1557-1571
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Thomas Divya,Sagar Satish,Liu Xiang,Lee Hye-Rim,Grunkemeyer James A.,Grandgenett Paul M.,Caffrey Thomas,O’Connell Kelly A.,Swanson Benjamin,Marcos-Silva Lara,Steentoft Catharina,Wandall Hans H.,Maurer Hans Carlo,Peng Xianlu Laura,Yeh Jen Jen,Qiu Fang,Yu Fang,Madiyalakan Ragupathy,Olive Kenneth P.,Mandel Ulla,Clausen Henrik,Hollingsworth Michael A.,Radhakrishnan Prakash^ORCID

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference29 articles.

1. Characterization of binding epitopes of CA125 monoclonal antibodies;Marcos-Silva;J. Proteome Res.,2014

2. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer;Remmers;Clin. Cancer Res.,2013

3. Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma;Liang;Mol. Cancer Res.,2017

4. The CA 125 gene: an extracellular superstructure dominated by repeat sequences;O’Brien;Tumour Biol.,2001

5. Glycosylation defining cancer malignancy: new wine in an old bottle;Hakomori;Proc. Natl. Acad. Sci. USA,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis;Cancer Immunology, Immunotherapy;2024-08-06

2. A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samples;2024-07-26

3. GDNF-induced phosphorylation of MUC21 promotes pancreatic cancer perineural invasion and metastasis by activating RAC2 GTPase;Oncogene;2024-07-17

4. MUC16: clinical targets with great potential;Clinical and Experimental Medicine;2024-05-17

5. Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer;Cancer Innovation;2024-05-12